Form 4: Director Sells Scholar Rock Shares Under 10b5-1 Plan

Scholar Rock Holding Corp. director Joshua Reed reported the sale of common stock valued at over $100,000, executed under a pre-arranged trading plan.

Summary

• Director Joshua Reed sold a total of 3,053 shares of Scholar Rock Holding Corp. common stock on July 1, 2026.
• The sales were conducted under a Rule 10b-5-1 trading plan established on March 21, 2026.
• The purpose of the sales was to cover tax obligations arising from the vesting and settlement of restricted stock units (RSUs).
• The weighted average sale price for the first transaction was $53.4958, resulting in the sale of 2,105 shares.
• The weighted average sale price for the second transaction was $54.2814, resulting in the sale of 948 shares.
• Following these transactions, Joshua Reed beneficially owns 20,466 shares (including 6,839 RSUs) and 19,518 shares (including 6,839 RSUs) respectively, held directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While insider selling can be a negative signal, the execution under a Rule 10b-5-1 plan for tax obligations is a standard and expected procedure, mitigating significant concern.

Positives

• The transactions were executed under a Rule 10b-5-1 plan, indicating pre-planned and potentially non-insider trading related sales.
• The sales were to cover tax obligations, a common and often necessary reason for stock sales by executives and directors.
• The director continues to hold a significant number of shares and RSUs after the sale.

Negatives

• A director has sold a portion of their holdings, which could be perceived negatively by the market, despite the stated reasons.
• The total value of shares sold is approximately $164,000, representing a reduction in the director's direct ownership.

Risks

• Potential for negative market perception due to insider selling, even if executed under a 10b5-1 plan.
• Future tax obligations could necessitate further sales of company stock.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding the company's future performance. It solely reports on past transactions by a director.

Industry Context

StockSavvy.ai notes that insider selling, particularly under Rule 10b5-1 plans, is a common occurrence in the biotechnology and pharmaceutical sectors. These plans are designed to allow insiders to sell shares over time without being subject to accusations of insider trading, often to diversify their holdings or meet financial obligations like taxes. The specific context of Scholar Rock Holding Corp. involves a director managing RSU vesting and associated tax liabilities.

Stakeholder Impact

• Shareholders: May interpret insider selling as a negative signal, though the Rule 10b5-1 plan and tax obligation context may temper this concern.
• Employees: The director's actions do not directly impact employee compensation or benefits as reported in this filing.
• Creditors: No direct impact on creditors is indicated by this transaction.
• Suppliers: No direct impact on suppliers is indicated by this transaction.

Next Steps

• Monitor future filings for any additional transactions by Joshua Reed or other insiders.
• Observe the company's overall stock performance and any upcoming financial reports for further insights.

Key Dates

Keywords

Scholar Rock Holding Corp, SRRK, Form 4, Insider Trading, Stock Sale, Rule 10b5-1, Restricted Stock Units, RSUs, Director Sale, Beneficial Ownership